Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CP 336156

Known as: CP-336,156 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
  • Drugs in R&D
  • 2005
  • Corpus ID: 42955649
Lasofoxifene [CP 336156] is a potent, nonsteroidal, tissue-selective estrogen receptor modulator (SERM). It has the bone-sparing… Expand
Highly Cited
2004
Highly Cited
2004
Neuroprotective effects of estradiol are well characterized in animal experimental models. However, in humans, the outcome of… Expand
2003
2003
Selective estrogen receptor modulators (SERMs) are estrogen receptor (ER) ligands that function as antagonists in some tissues… Expand
2002
2002
Estrogen replacement therapy is reported to reduce the incidence of vertebral fractures in postmenopausal women, however, its… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2001
Highly Cited
2001
The purpose of this study was to evaluate if long‐term (6 months) treatment with lasofoxifene (LAS), a new selective estrogen… Expand
Review
2000
Review
2000
Selective oestrogen receptor modulators (SERMs) are structurally diverse non-steroidal compounds that bind to oestrogen receptors… Expand
  • figure 1
  • table I
  • table II
  • table III
Highly Cited
2000
Highly Cited
2000
It has been well documented that selective estrogen receptor modulators (SERMs) can prevent bone loss in ovariectomized rats and… Expand
2000
2000
  • P. Neven
  • European journal of cancer
  • 2000
  • Corpus ID: 40941709
Chemical modi®cations of the synthetic stilbene nucleus of diethylstilboestrol led to the non-toxic triphenylethylene, tamoxifen… Expand
Highly Cited
1998
Highly Cited
1998
We have discovered a new, nonsteroidal, potent estrogen agonist/antagonist, CP-336,156. CP-336,156 binds selectively and with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Highly Cited
1998
Highly Cited
1998
We have discovered a new, nonsteroidal, potent estrogen agonist/antagonist, CP-336,156. CP-336,156 binds selectively and with… Expand